TERN Terns Pharmaceuticals, Inc.

Fundamentals / CIK 0001831363 / USD

Terns Pharmaceuticals, Inc. reported $1.03B in total assets and a net loss of $96.21M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open TERN in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

6 fiscal years (2020 to 2025), reported in USD.

$11.15M$5.57M$0-$90.04MFY 2020 Revenue: $0FY 2020 Net Income: -$40.05M2020FY 2021 Revenue: $1.00MFY 2021 Net Income: -$50.16M2021FY 2022 Revenue: $0FY 2022 Net Income: -$60.34M2022FY 2023 Net Income: -$90.21M2023FY 2024 Net Income: -$88.85M2024FY 2025 Net Income: -$96.21M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue -- -- -- $0 $1.00M $0
Research & Development $77.89M $70.11M $63.50M $39.62M $31.31M $28.03M
Operating Income -$110.1M -$101.9M -$102.6M -$62.03M -$49.86M -$37.02M
EBITDA -$110.0M -$101.6M -$102.3M -$61.55M -$49.35M -$36.63M
Income Before Tax -$95.63M -$88.59M -$89.97M -$59.99M -$49.65M -$39.76M
Income Tax Expense $581K $260K $239K $358K $508K $813K
Net Income -$96.21M -$88.85M -$90.21M -$60.34M -$50.16M -$40.05M
Basic EPS -$1.03 -$1.12 -$1.27 -$1.67 -$2.21 -$102.93
Diluted EPS -$1.03 -$1.12 -$1.27 -$1.67 -$2.21 -$102.93
Basic Shares Outstanding 93.2M 79.5M 71.3M 36.0M 22.7M 285.2K
Diluted Shares Outstanding 93.2M 79.5M 71.3M 36.0M 22.7M 285.2K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31
Research & Development $18.90M $19.92M $20.35M $18.72M $18.00M $15.17M $18.35M $18.59M
Operating Income -$27.60M -$27.72M -$27.38M -$27.43M -$25.95M -$24.94M -$25.54M -$25.45M
EBITDA -$27.59M -$27.70M -$27.37M -$27.37M -$25.88M -$24.86M -$25.45M -$25.36M
Income Before Tax -$23.19M -$24.59M -$24.03M -$23.82M -$21.76M -$21.88M -$22.68M -$22.28M
Income Tax Expense $383K $46K $64K $88K $40K $62K $61K $97K
Net Income -$23.57M -$24.64M -$24.09M -$23.91M -$21.80M -$21.95M -$22.74M -$22.37M
Basic EPS -- -$0.27 -$0.26 -$0.26 -- -$0.28 -$0.31 -$0.30
Diluted EPS -- -$0.27 -$0.26 -$0.26 -- -$0.28 -$0.31 -$0.30
Basic Shares Outstanding -- 91.7M 91.6M 91.5M -- 77.8M 74.5M 74.4M
Diluted Shares Outstanding -- 91.7M 91.6M 91.5M -- 77.8M 74.5M 74.4M

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $524.7M $161.4M $79.93M $143.2M $47.70M $74.85M
Short-Term Investments $494.2M $196.7M $183.5M $139.9M $118.3M $0
Cash & Short-Term Investments $1.02B $358.2M $263.4M $283.1M $166.0M $74.85M
Total Current Assets $1.02B $362.1M $267.4M $285.2M $166.9M $90.87M
Property, Plant & Equipment, Net $47K $222K $506K $757K $1.05M $1.18M
Other Non-Current Assets $0 $350K $56K $37K $94K $246K
Total Non-Current Assets $884K $1.82M $1.08M $1.84M $1.14M $1.42M
Total Assets $1.03B $363.9M $268.5M $287.0M $168.1M $92.29M
Accounts Payable $1.72M $2.15M $2.52M $1.65M $2.13M $935K
Total Current Liabilities $16.41M $15.65M $11.94M $8.47M $6.82M $22.82M
Long-Term Debt -- -- $0 $544K -- --
Total Non-Current Liabilities $2.14M $2.41M $1.21M $1.61M $947K $877K
Total Liabilities $18.55M $18.06M $13.15M $10.08M $7.77M $23.70M
Total Debt (incl. Leases) $919K $1.35M $603K $1.75M -- --
Common Stock $11K $9.0K $6.0K $5.0K $3.0K $0
Retained Earnings -$517.7M -$421.5M -$332.6M -$242.4M -$182.1M -$131.9M
Accumulated Other Comp. Income $260K -$279K -$19K -$822K -$338K -$124K
Total Stockholders' Equity $1.01B $345.9M $255.4M $276.9M $160.3M -$117.4M
Total Equity $1.01B $345.9M $255.4M $276.9M $160.3M -$117.4M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31
Cash & Cash Equivalents $524.7M $150.7M $146.0M $139.0M $161.4M $270.1M $91.50M $65.10M
Short-Term Investments $494.2M $144.9M $169.5M $195.2M $196.7M $102.6M $133.8M $175.6M
Cash & Short-Term Investments $1.02B $295.6M $315.4M $334.3M $358.2M $372.8M $225.3M $240.7M
Total Current Assets $1.02B $300.3M $319.0M $337.7M $362.1M $376.5M $230.2M $245.9M
Property, Plant & Equipment, Net $47K $59K $70K $82K $222K $295K $370K $447K
Other Non-Current Assets $0 $359K $356K $351K $350K $56K $55K $55K
Total Non-Current Assets $884K $1.36M $1.46M $1.57M $1.82M $1.73M $642K $871K
Total Assets $1.03B $301.7M $320.4M $339.3M $363.9M $378.2M $230.9M $246.8M
Accounts Payable $1.72M $2.95M $2.85M $2.78M $2.15M $1.79M $1.87M $1.70M
Total Current Liabilities $16.41M $15.39M $12.91M $10.94M $15.65M $11.41M $10.96M $8.83M
Long-Term Debt -- -- -- -- -- $1.03M $0 $0
Total Non-Current Liabilities $2.14M $2.20M $2.27M $2.34M $2.41M $2.35M $1.24M $1.22M
Total Liabilities $18.55M $17.59M $15.19M $13.27M $18.06M $13.76M $12.20M $10.05M
Total Debt (incl. Leases) $919K $1.03M $1.13M $1.24M $1.35M $2.34M $249K $427K
Common Stock $11K $9.0K $9.0K $9.0K $9.0K $8.0K $7.0K $6.0K
Retained Earnings -$517.7M -$494.1M -$469.5M -$445.4M -$421.5M -$399.7M -$377.7M -$355.0M
Accumulated Other Comp. Income $260K $109K -$22K $51K -$279K $160K -$443K -$321K
Total Stockholders' Equity $1.01B $284.1M $305.2M $326.0M $345.9M $364.5M $218.7M $236.7M
Total Equity $1.01B $284.1M $305.2M $326.0M $345.9M $364.5M $218.7M $236.7M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$96.21M -$88.85M -$90.21M -$60.34M -$50.16M -$40.57M
Depreciation & Amortization $90K $319K $292K $484K $512K $394K
Stock-Based Compensation $13.40M $15.63M $25.54M $10.77M $8.15M $1.69M
Change in Payables -$512K -$367K $1.15M -$722K $1.73M -$1.15M
Operating Cash Flow -$82.18M -$70.02M -$67.39M -$49.11M -$41.83M -$29.81M
Capital Expenditure $0 -$42K -$52K -$275K -$340K -$584K
Free Cash Flow -$82.18M -$70.06M -$67.44M -$49.38M -$42.17M -$30.39M
Purchases of Investments -$405.0M -$169.9M -$275.8M -$139.7M -$166.3M -$715K
Investing Cash Flow -$298.0M -$12.41M -$37.99M -$22.27M -$119.7M $6.69M
Common Stock Issued $513K $623K $410K $81.11M $0 --
Financing Cash Flow $743.5M $164.0M $41.95M $167.1M $134.4M $85.52M
Net Change in Cash $363.3M $81.51M -$63.31M $95.54M -$27.16M $62.48M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31
Net Income -$23.57M -$24.64M -$24.09M -$23.91M -$21.80M -$21.95M -$22.74M -$22.37M
Depreciation & Amortization $12K $12K $11K $55K $66K $83K $88K $82K
Stock-Based Compensation $3.35M $3.34M $3.03M $3.68M $3.02M $4.16M $4.42M $4.03M
Change in Payables -$1.31M $97K $71K $630K $415K -$140K $172K -$814K
Operating Cash Flow -$19.08M -$19.77M -$18.88M -$24.44M -$14.58M -$16.45M -$16.18M -$22.80M
Capital Expenditure $0 $0 $0 $0 $0 $0 -$13K -$29K
Free Cash Flow -$19.08M -$19.77M -$18.88M -$24.44M -$14.58M -$16.45M -$16.19M -$22.83M
Purchases of Investments -$380.0M $0 $0 -$25.04M -$119.3M $0 $0 -$50.59M
Investing Cash Flow -$350.0M $24.50M $25.50M $1.96M -$94.35M $31.75M $42.19M $8.00M
Financing Cash Flow $743.1M $0 $324K $68K $304K $163.3M $399K $0
Net Change in Cash $374.0M $4.73M $6.94M -$22.42M -$108.7M $178.6M $26.40M -$14.83M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -- -- -- -- -4986.0% --
Net Profit Margin -- -- -- -- -5015.8% --
Return on Equity (ROE) -9.6% -25.7% -35.3% -21.8% -31.3% --
Return on Assets (ROA) -9.4% -24.4% -33.6% -21.0% -29.8% -43.4%
Current Ratio 62.41x 23.14x 22.39x 33.68x 24.48x 3.98x
Quick Ratio 62.09x 22.89x 22.06x 33.43x 24.34x 3.28x
Debt to Equity 0.00x 0.00x 0.00x 0.01x -- --
Revenue Growth (YoY) -- -- -- -100.0% -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31
Return on Equity (ROE) -9.6% -33.2% -30.1% -27.7% -25.7% -24.2% -43.9% -38.5%
Return on Assets (ROA) -9.4% -31.3% -28.6% -26.6% -24.4% -23.3% -41.5% -36.9%
Current Ratio 62.41x 19.52x 24.70x 30.89x 23.14x 32.99x 21.02x 27.85x
Quick Ratio 62.09x 19.21x 24.43x 30.57x 22.89x 32.67x 20.57x 27.26x
Debt to Equity 0.00x 0.00x 0.00x 0.00x 0.00x 0.01x 0.00x 0.00x
Source: SEC EDGAR CompanyFacts (CIK 0001831363) · from March 31, 2020 Data through December 31, 2025 · synced Nov 20, 2026, 05:14 UTC · Open in terminal